Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:12-Oxo-LTB4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST002823 AN004604 Smoking Induced Gut Microbial Dysbiosis Mediates Cancer Progression Through Adaptive Immune System Modulation Feces Mouse Cancer University of Alabama, Birmingham LC-MS
ST002444 AN003981 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami LC-MS
ST002444 AN003982 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002307 AN003769 Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002307 AN003769 Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002283 AN003729 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer Walter and Eliza Hall Institute of Medical Research LC-MS
ST001855 AN003006 The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 1) Kidney Mouse Kidney disease Children's Hospital of Nanjing Medical University LC-MS
ST001638 AN002680 Metabolomics analysis of Vehicle (DMSO/PBS; (1:1) v/v) and DRB18 (10 mg/kg) treated A549 xenograft tumors Tumor cells Mouse Cancer Ohio University LC-MS
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001223 AN002036 Host Metabolic Response in Early Lyme Disease Blood Human Lyme disease Colorado State University LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
  logo